Krilogy Financial’s Immunomedics Inc IMMU Stock Holding History

Krilogy Financial’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-200	Closed	-$4K	–	772
2018 Q3	$4K	Buy	+200	New	+$4.74K	﹤0.01%	664

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Krilogy Financial's IMMU Position: Q4 2018 in Review

Krilogy Financial sold out of Immunomedics Inc (IMMU) in Q4 2018, closing a stake of 200 shares — an estimated $4K sold.

Krilogy Financial first reported a position in IMMU in Q3 2018 and held it in 1 quarter. The position peaked at $4K in Q3 2018. 205 funds tracked by Wall St. Rank hold IMMU as of Q4 2018.

Krilogy Financial reported no remaining Immunomedics Inc position as of Q4 2018 after selling out during the quarter.
Krilogy Financial sold 200 Immunomedics Inc shares in Q4 2018, an estimated $4K.
Krilogy Financial first reported a position in Immunomedics Inc in Q3 2018 and held it in 1 quarter.
Krilogy Financial's Immunomedics Inc position peaked at $4K in Q3 2018.
205 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2018.

Based on Krilogy Financial's 13F filing for Q4 2018, filed 14 Feb 2019.